E-LIB Suche - Ergebnisse für: Guss, Valerie

1

Identification and characterization of a MAPT-targeting loc..:

Easton, Amy ; Jensen, Marianne L. ; Wang, Congwei...
Molecular Therapy - Nucleic Acids. 29 (2022) - p. 625-642 , 2022

Link: https://doi.org/10.1016/..

2

Utility of high resolution accurate mass spectrometry (HRMS..:

Cantone, Joseph L. ; Polson, Craig ; Wei, Cong...
Analytical Methods. 9 (2017) 23 - p. 3477-3484 , 2017

Link: https://doi.org/10.1039/..

3

Identification and Preclinical Pharmacology of theγ-Secreta..:

Toyn, Jeremy H. ; Thompson, Lorin A. ; Lentz, Kimberley A....
International Journal of Alzheimer's Disease. 2014 (2014) - p. 1-22 , 2014

Link: https://doi.org/10.1155/..

4

Characterization of Novel CSF Tau and ptau Biomarkers for A..:

Meredith Jr., Jere E. ; Sankaranarayanan, Sethu ; Guss, Valerie...
PLoS ONE. 8 (2013) 10 - p. e76523 , 2013

Link: https://doi.org/10.1371/..

5

Novel CSF Tau Assays Demonstrate Different Abnormalities in..:

Wagshal, Dana ; Sankaranarayanan, Sethu ; Guss, Valerie...
Neurology. 80 (2013) 7_supplement - p. , 2013

Link: https://doi.org/10.1212/..

6

Novel CSF Tau Assays Demonstrate Different Abnormalities in..:

Wagshal, Dana ; Sankaranarayanan, Sethu ; Guss, Valerie...
Neurology. 80 (2013) 7_supplement - p. , 2013

Link: https://doi.org/10.1212/..

7

P1‐009: Novel human CSF tau‐fragment and pTau assays for di..:

Sankaranarayanan, Sethu ; Meredith, Jere ; Guss, Valerie...
Alzheimer's & Dementia. 8 (2012) 4S_Part_3 - p. , 2012

Link: https://doi.org/10.1016/..

8

P2‐039: Novel tau fragments are present in human CSF:

Meredith, Jere ; Slemmon, Randall ; Guss, Valerie...
Alzheimer's & Dementia. 8 (2012) 4S_Part_8 - p. , 2012

Link: https://doi.org/10.1016/..

9

2-(N-Benzyl-N-phenylsulfonamido)alkyl amide derivatives as ..:

Parker, Michael F. ; Barten, Donna M. ; Bergstrom, Carl P....
Bioorganic & Medicinal Chemistry Letters. 22 (2012) 22 - p. 6828-6831 , 2012

Link: https://doi.org/10.1016/..

10

Measurement of Aβ1–42 in cerebrospinal fluid is influenced ..:

Slemmon, J. Randall ; Meredith, Jere ; Guss, Valerie...
Journal of Neurochemistry. 120 (2011) 2 - p. 325-333 , 2011

Link: https://doi.org/10.1111/..

11

P3‐288: Gamma‐secretase inhibitors have intrinsically diffe..:

Burton, Catherine R. ; Meredith, Jere E. ; Toyn, Jeremy H....
Alzheimer's & Dementia. 6 (2010) 4S_Part_17 - p. , 2010

Link: https://doi.org/10.1016/..

12

P4‐020: Separation of Aβ Reduction from Notch Toxicity with..:

Meredith, Jere ; Barten, Donna ; Burton, Catherine...
Alzheimer's & Dementia. 6 (2010) 4S_Part_20 - p. , 2010

Link: https://doi.org/10.1016/..

13

Viable mouse gene ablations that robustly alter brain Aβ le..:

Toyn, Jeremy H ; Lin, Xu-Alan ; Thompson, Mark W...
BMC Neuroscience. 11 (2010) 1 - p. , 2010

Link: https://doi.org/10.1186/..

14

P2‐346: PGP efflux and other factors limit brain Aβ reducti..:

Meredith, Jere ; Thompson, Lorin ; Toyn, Jeremy...
Alzheimer's & Dementia. 4 (2008) 4S_Part_14 - p. , 2008

Link: https://doi.org/10.1016/..

15

Nitrogen-appended N-alkylsulfonamides as inhibitors of γ-se..:

Bergstrom, Carl P. ; Sloan, Charles P. ; Wang, Henry H....
Bioorganic & Medicinal Chemistry Letters. 18 (2008) 1 - p. 175-178 , 2008

Link: https://doi.org/10.1016/..